Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases

被引：323
作者：
Sonnweber, Thomas [1 ]
Pizzini, Alex [1 ]
Nairz, Manfred [1 ]
Weiss, Guenter [1 ]
Tancevski, Ivan [1 ]
机构：
[1] Med Univ Innsbruck, Dept Internal Med 2, A-6020 Innsbruck, Austria
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2018年 / 19卷 / 11期
关键词：
arachidonic acid; eicosanoids; metabolic disease; obesity; nonalcoholic fatty liver disease; diabetes; atherosclerosis; cardiovascular disease; cholesterol; FATTY LIVER-DISEASE; SOLUBLE EPOXIDE HYDROLASE; RECEPTOR ANTAGONIST MONTELUKAST; ASPIRIN-TRIGGERED LIPOXIN; LEUKOTRIENE B-4 RECEPTOR; INSULIN-RESISTANCE; EPOXYEICOSATRIENOIC ACIDS; MYOCARDIAL ISCHEMIA; OXIDATIVE STRESS; LIPID MEDIATORS;
D O I：
10.3390/ijms19113285
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Lipid and immune pathways are crucial in the pathophysiology of metabolic and cardiovascular disease. Arachidonic acid (AA) and its derivatives link nutrient metabolism to immunity and inflammation, thus holding a key role in the emergence and progression of frequent diseases such as obesity, diabetes, non-alcoholic fatty liver disease, and cardiovascular disease. We herein present a synopsis of AA metabolism in human health, tissue homeostasis, and immunity, and explore the role of the AA metabolome in diverse pathophysiological conditions and diseases.
引用
收藏
页数：26
相关论文
共 50 条
[31]   Vascular proteomics in metabolic and cardiovascular diseases [J].
Lynch, M. ;
Barallobre-Barreiro, J. ;
Jahangiri, M. ;
Mayr, M. .
JOURNAL OF INTERNAL MEDICINE, 2016, 280 (04) :325-338
[32]   Metabolic Syndrome and Cardiovascular Diseases in Korea [J].
Suh, Sunghwan ;
Lee, Moon-Kyu .
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2014, 21 :S31-S35
[33]   The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases [J].
S. Park ;
K. W. Mathis ;
I. K. Lee .
Reviews in Endocrine and Metabolic Disorders, 2014, 15 :45-53
[34]   Sirtuins and NAD+ in the Development and Treatment of Metabolic and Cardiovascular Diseases [J].
Kane, Alice E. ;
Sinclair, David A. .
CIRCULATION RESEARCH, 2018, 123 (07) :868-885
[35]   Mast Cell Chymase and Tryptase as Targets for Cardiovascular and Metabolic Diseases [J].
He, Aina ;
Shi, Guo-Ping .
CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (06) :1114-1125
[36]   The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases [J].
Park, S. ;
Mathis, K. W. ;
Lee, I. K. .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2014, 15 (01) :45-53
[37]   Hydrogen Therapy in Cardiovascular and Metabolic Diseases: from Bench to Bedside [J].
Zhang, Yaxing ;
Tan, Sihua ;
Xu, Jingting ;
Wang, Tinghuai .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (01) :1-10
[38]   Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases [J].
Ackers, Ian ;
Malgor, Ramiro .
DIABETES & VASCULAR DISEASE RESEARCH, 2018, 15 (01) :3-13
[39]   Air pollution combined with high-fat feeding aggravates metabolic and cardiovascular diseases: A dangerous, oxidative, and immune-inflammatory association [J].
Costa-Beber, Lilian Correa ;
Goettems-Fiorin, Pauline Brendler ;
dos Santos, Jaine Borges ;
Friske, Paula Tais ;
Frizzo, Matias Nunes ;
Heck, Thiago Gomes ;
Ludwig, Mirna Stela .
LIFE SCIENCES, 2023, 317
[40]   Protein tyrosine phosphatase 1B in metabolic and cardiovascular diseases: from mechanisms to therapeutics [J].
Sun, Yan ;
Dinenno, Frank A. ;
Tang, Peiyang ;
Kontaridis, Maria I. .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
12345